ResMed's healthy advantage

A lower dollar and cheap offshore operating costs have contributed to ResMed's above-average returns, while its international competitors' revenues have shrunk.

Sleep apnea device maker ResMed Inc has given a rosy report to the market, with net profit for the year up 21% to over $US 307 million and revenue up 11% to $1.5 billion. In dollar terms it was record revenue and income for the quarter and fiscal year. Locally, the company's share price is up nearly 80% over the past 12 months, easily leading its peers across the technology side of the healthcare industry.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles